🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Diabetes Mellitus, Type I

Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes NCT05819138Phase 32 sites📍 Aurora📍 Seattle University of Colorado, Denver · Tests: Semaglutide Pen Injector, Placebo Exploring Skin Barrier Function, Recurrence of Diabetes Device-Related Contact Dermatitis, and Evaluation of Hydrocolloid and Silicone-Based Patches for Its Prevention in Children and Adolescents With Type 1 Diabetes NCT07767461NA1 site📍 Copenhagen Steno Diabetes Center Copenhagen · Tests: hydrocolloid patch as patch used in the Sandwich method, Silicone-based patch as patch used in the Sandwitch method Efficacy of Glycemic Improvement Project (GLITTER Study) in Type 1 Diabetes-GLITTER Study 2 NCT07097818NA10 sites📍 Beijing📍 Quanzhou📍 Shenzhen Second Xiangya Hospital of Central South University · Tests: T1D team, structured education, peer support , and diabetes technologies, Routine Management Registry of Patients Living With Type 1 Diabetes NCT03720197n/a7 sites📍 Edmonton📍 Montreal📍 Montreal Institut de Recherches Cliniques de Montreal · Tests: Online questionnaire - Phase 1, Online questionnaire - Phase 2, Online questionnaire - Phase 3, Food questionnaire, Ped… Effect of Inhaled Technosphere Insulin vs RAA Insulin on Exercise-Induced Hypoglycemia in Adults With T1D Using Automated Insulin Delivery NCT06880835NA3 sites📍 Louisville📍 Philadelphia📍 Seattle Jaeb Center for Health Research · Tests: Control IQ + sleep or exercise activity with TI Insulin Delivery With Self-Adjusting Closed-Loop and Behavioral Glycemic Control Enhanced by Prediction NCT07507708NA1 site📍 Charlottesville Sue Brown · Tests: Automated Insulin Delivery (AID), AIDANET + Fully Closed Loop (FCL), AIDANET + Anticipatory Closed Loop (ACL) Pharmacokinetic and Early Efficacy of OPT101 in Patients With Type 1 Diabetes Mellitus NCT06964087Phase 25 sites📍 Birmingham📍 Walnut Creek📍 Aurora Op-T LLC · Tests: OPT101, OPT101 Placebo to Match (PTM) Chronotype of Patients With Diabetes and Effect on Glycaemic Control NCT02973412n/a1 site📍 Leicester University of Leicester Effect of Ear Massage on Stress, Anxiety, and Sleep Quality in Parents of Children With Type 1 Diabetes NCT06829251NA1 site📍 Mersin Mersin University · Tests: Effective Ear Massage, Sham Ear Massage Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System NCT07579702NA11 sites📍 Los Angeles📍 Santa Barbara📍 Aurora Insulet Corporation · Tests: Omnipod 5 System, Omnipod 6 System Carbohydrate Beta Cell Function and Glucose Control in Children With Diabetes NCT05899166NA1 site📍 Boston Boston Children's Hospital · Tests: Ketogenic diet, food delivery and education, Standard diet, food delivery and education Continuous Glucose Monitoring in High-Risk Children and Youth With Type 1 Diabetes in the Dominican Republic NCT07742306n/a3 sites📍 Santiago de los Caballeros📍 Santo Domingo📍 Santo Domingo Life for a Child Program, Diabetes Australia · Tests: Intermittent CGM The Effect of Glycemic Control and of GLP-1 Receptor Agonism on Islet GLP-1 in People With Type 1 and Type 2 Diabetes NCT06976619Phase 21 site📍 Rochester Mayo Clinic · Tests: Liraglutide Pen Injector, Saline Injections Evaluation of the Accuracy and Safety of a Continuous Glucose Monitoring System NCT07745244NA1 site📍 Zibo SiBionics, Co, Ltd · Tests: GS3 CGM Diabetes RElated to Acute Pancreatitis and Its Mechanisms: Metabolic Outcomes Using Novel CGM Metrics NCT06401577n/a13 sites📍 Los Angeles📍 Los Angeles📍 Stanford Milton S. Hershey Medical Center · Tests: Dexcom Continuous Glucose Monitor (CGM) Safety and Efficacy of CELZ-201 in Patients With Recent Onset Type 1 Diabetes NCT05626712Phase 1, Phase 21 site📍 Miami Creative Medical Technology Holdings Inc · Tests: CELZ-201 Administration, Control Group Disentangling the Effect of Brain Insulin Resistance on Brain Health NCT07374705n/a3 sites📍 Glostrup Municipality📍 Herlev📍 Ulm Henrik Bo Wiberg Larsson Effects of Circadian Rhythm on Glycemic Regulation During Continuous Moderate Exercise and Intense Intermittent Disease in Adolescents Living With Type 1 Diabetes NCT06803446NA1 site📍 Loos Lille University · Tests: physical test The iLet Experience Study NCT06891898n/a1 site📍 Irvine Beta Bionics, Inc. · Tests: iLet Dosing Decision Software Telemedicine-Delivered Unified Protocol for Cognitive Behavioral Therapy for Anxiety and Depression NCT05734313NA2 sites📍 Boston📍 The Bronx Albert Einstein College of Medicine · Tests: Unified protocol for cognitive behavioral therapy (UP-CBT), Continuous Glucose Monitoring (CGM) Do "sugar Swings" Impact the Brain Function and the Eating Behaviors of People with Type 1 Diabetes NCT05487534n/a2 sites📍 Montreal📍 Québec Laval University · Tests: Observational BeAT1D: Benign Autoimmunity and Type 1 Diabetes NCT05139784n/a17 sites📍 Bobigny📍 Bondy📍 Colombes Institut National de la Santé Et de la Recherche Médicale, … · Tests: Biosampling Effect of Advanced Hybrid Closed Loop System, MiniMed 780G in Newly Diagnosed Children and Adolescents With Type 1 Diabetes on Glycemic Control and Patient Reported Outcomes Compared to Standard Insulin Therapy Historical Data (AHCL in New Onset T1D Children Study) NCT06919029n/a1 site📍 Athens National and Kapodistrian University of Athens · Tests: Advanced Hybrid Closed Loop from onset of type 1 diabetes in children Long Term Follow up of Recipients of Functional Islet Allografts NCT01999374n/a1 site📍 Miami Rodolfo Alejandro Cardiometabolic Benefit of Reducing Iatrogenic Hyperinsulinemia Using Insulin Adjunctive Therapy in Type 1 Diabetes NCT06609356EARLY Phase 11 site📍 Nashville Vanderbilt University Medical Center · Tests: Study Visit 1, Placebo, Study Visit 2, Sodium Glucose Co-transporter 2 (SGLT2) Inhibitor VV-14299 and VV-14300 for the Treatment of Type 1 Diabetes NCT07829302Phase 1, Phase 21 site📍 Melbourne Kriya Therapeutics, Inc. · Tests: VV-14300, VV-14299 Randomized Trial of Supplemental Synchronous and Asynchronous Telehealth to Improve Glycemic Control for Pediatric Patients With Type 1 Diabetes NCT04428658NA1 site📍 Sacramento University of California, Davis · Tests: Supplemental video visits, Standard of Care, Supplemental remote monitoring RT-CGM in Young Adults at Risk of DKA NCT04039763NA1 site📍 London Imperial College London · Tests: Dexcom G6, Self monitoring of blood glucose Use of CGM in Kidney Transplant Recipients NCT04783441NA1 site📍 Sacramento University of California, Davis · Tests: Dexcom G6, Dexcom G6 blinded sensor Drawing and Writing Activities in Adolescents With Type 1 Diabetes NCT07830082NA1 site📍 Ankara Gazi University · Tests: Drawing and Writing Intervention
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy